8 September 2022: Viona launches Zonisamide Capsules, USP

10 August 2022: Viona launches Aripiprazole Orally Disintegrating Tablets, USP

18 July 2022: Viona launches Modafinil Tablets, USP

7 January 2022: Viona issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg

11 June 2021: Viona issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg

We’re setting a new standard for high-quality, low-cost generics.

Viona Pharmaceuticals is a fast-growing generic pharmaceutical company with its headquarters in Cranford, NJ. Viona is a wholly owned indirect subsidiary of Zydus Lifesciences Limited, a fully integrated, global healthcare provider.

Learn More About Us

Modafinil Tablets, USP

COMPARED TO: Provigil®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Wakefulness Promoting Agent

Adapalene and Benzoyl Peroxide Topical Gel

COMPARED TO: Epiduo Forte
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Acne agents

Levofloxacin Tablets, USP

COMPARED TO: Levaquin®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Synthetic Antibacterial Agent

PRODUCTS

Viona is currently marketing a range of Oral Solids and Topical products. We have a vast number of generic pharmaceutical products in the pipeline, which we are excited to introduce to the market soon.
Explore our Products